Newhold Investment Corp IV (NHIV) FinancialsNHIVFinancialNewhold Investment Corp IV

In the context of the broader market, NHIV competes directly with industry leaders such as ISNR and PAII. With a market capitalization of $278.04M, it holds a significant position in the sector. When comparing efficiency, NHIV's gross margin of N/A stands against ISNR's N/A and PAII's N/A. Such benchmarking helps identify whether Newhold Investment Corp IV is trading at a premium or discount relative to its financial performance.

The financial performance shows a significant improvement in net income from -$38,000 in Q1 2026 to $854,000 in Q2 2026, but the overall financial health remains concerning with a current ratio of 0.01 and total equity of -$60,000.